Dudediligence.

Repligen Corporation

RGENNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$15.3M

14 notices · 91,970 sh

Oct 2025 to Oct 2026

Reported ·

$9,123,244

16 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

7 of 16 reported sales carry the 10b5-1 box. Together they are 0.10% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-10-05: Loeillot Olivier, Form 1442026-10-05: Loeillot Olivier, Form 1442026-09-24: Loeillot Olivier, Form 1442026-09-21: Loeillot Olivier, Form 1442026-09-04: Loeillot Olivier, Form 1442026-08-20: Loeillot Olivier, Form 1442026-07-16: Garland Jason K, Form 1442026-06-25: Garland Jason K, Form 1442026-04-21: Loeillot Olivier, Form 1442025-12-17: DAWES KAREN A, Form 1442025-11-25: Loeillot Olivier, Form 1442025-11-18: Bylund James, Form 1442025-11-13: Hunt Anthony, Form 1442025-11-12: Hunt Anthony, Form 1442025-11-12: Hunt Anthony, sold2025-11-13: Hunt Anthony, sold2025-11-18: Bylund James, sold2025-11-25: Loeillot Olivier, sold2025-12-17: DAWES KAREN A, sold2026-04-21: Loeillot Olivier, sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-10-05Loeillot Olivier, Chief Executive Officer$798,380
4,202 shplan 2025-08-19Form 4s on file end Jun 23144 ↗
2026-10-05Loeillot Olivier, Chief Executive Officer$238,274
1,333 shplan 2025-08-19Form 4s on file end Jun 23144 ↗
2026-09-24Loeillot Olivier, Chief Executive Officer$2,459,740
12,946 shplan 2025-08-19Form 4s on file end Jun 23144 ↗
2026-09-21Loeillot Olivier, Chief Executive Officer$976,680
5,426 shplan 2025-08-19Form 4s on file end Jun 23144 ↗
2026-09-04Loeillot Olivier, Chief Executive Officer$503,507
3,035 shplan 2025-08-19Form 4s on file end Jun 23144 ↗
2026-08-20Loeillot Olivier, Chief Executive Officer$976,680
5,426 shplan 2025-08-19Form 4s on file end Jun 23144 ↗
2026-07-16Garland Jason K, CFO$79,500
530 shplan 2025-12-08Form 4s on file end Jun 23144 ↗
2026-06-25Garland Jason K, CFO$106,285
733 shplan 2025-12-08144 ↗
Form 4, 2026-06-26: sold 733 at $145.00 Form 4 ↗
2026-04-21Loeillot Olivier, Chief Executive Officer$536,480
3,832 shplan 2025-08-19144 ↗
Form 4, 2026-04-22: sold 3,832 at $140.00 Form 4 ↗
2025-12-17DAWES KAREN A, Director$44,275
275 shno plan date144 ↗
Form 4, 2025-12-18: sold 275 at $161.00 Form 4 ↗
2025-11-25Loeillot Olivier, Chief Executive Officer$1,196,970
7,041 shplan 2024-12-12144 ↗
Form 4, 2025-11-26: sold 7,041 at $170.00 Form 4 ↗
2025-11-18Bylund James, Chief Operating Officer$331,304
2,191 shno plan date144 ↗
Form 4, 2025-11-19: sold 2,191 at $151.21 Form 4 ↗
2025-11-13Hunt Anthony, Director$3,092,327
20,000 shno plan date144 ↗
Form 4, 2025-11-14: sold 20,000 at $154.61 Form 4 ↗
2025-11-12Hunt Anthony, Director$3,921,981
25,000 shplan 2024-12-09144 ↗
Form 4, 2025-11-13: sold 25,000 at $156.88 Form 4 ↗